Washington D.C. is approving medical cannabis cardholders from eight new states for the District’s medical program; 29 states have now been approved, with four more still under review.
Researchers have known about the pain relieving potential of cannabis for decades, but they have had to wait until now to determine how the plant creates such effective substances. Their findings may help provide a solution to the opioid crisis.